Johnson & Johnson financials
Key figures from Johnson & Johnson's filings with the U.S. Securities and Exchange Commission: the latest quarter against a year earlier, and the trend across recent quarters and fiscal years.
Latest quarter vs a year earlier
| Metric | Jun 2026 | Jun 2025 | Change |
|---|---|---|---|
| Revenue | $25.3B | $23.7B | +6.6% |
| Net income | $5.5B | $5.5B | -0.1% |
| Free cash flow | $7.3B | $2.8B | +157.3% |
| Gross margin | 68.2% | 67.9% | +0.3 pts |
| Operating margin | — | — | — |
| Net margin | 21.9% | 23.3% | -1.5 pts |
Quarterly trend
Fiscal years
| Fiscal year | Revenue | Net income | Net margin | Free cash flow | EPS (diluted) |
|---|---|---|---|---|---|
| FY Dec 2025 | $94.2B | $26.8B | 28.5% | $19.7B | $11.03 |
| FY Dec 2024 | $88.8B | $14.1B | 15.8% | $19.8B | $5.79 |
| FY Dec 2023 | $85.2B | $35.2B | 41.3% | $18.2B | $13.72 |
| FY Jan 2023 | $80.0B | $17.9B | 22.4% | $17.2B | $6.73 |
| FY Jan 2022 | $78.7B | $20.9B | 26.5% | $19.8B | $7.81 |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters. All figures from company filings with the SEC.